ExodusPoint Capital Management »

Lyell Immunopharma shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $262k 8.5k 30.78

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Vanguard Group
Foresite Capital Management IV
Orland Properties
Almitas Capital
Foresite Capital Management V
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding
Millennium Management

View all funds holding Lyell Immunopharma